需求少+摊上超3亿诉讼，环球印务大幅调减募投项目投入

Core Viewpoint - The company announced changes to its fundraising projects, including the completion and adjustment of certain projects, as well as the permanent allocation of surplus funds to working capital due to unmet market demand and increased competition in the pharmaceutical industry [1][4][6]. Fundraising Project Adjustments - The company plans to permanently allocate surplus fundraising of 45.7502 million yuan to working capital, which accounts for 6.20% of the net fundraising amount [2][4]. - The "Pharmaceutical Packaging Folding Box Expansion and Intelligent Manufacturing Project" will be concluded, with total investment reduced from 280.2 million yuan to 49.37 million yuan, and the use of fundraising decreased from 87.5326 million yuan to 42.0384 million yuan [3][4]. - The "Global Printing Expansion and Green Packaging Intelligent Manufacturing Industrial Park (Phase I) Project" has been postponed to December 2027 due to similar reasons of unmet demand and competition [5][6]. Financial Performance and Legal Issues - The company has faced two consecutive years of losses, with a significant decline in revenue and a net profit loss of 20.0619 million yuan in the first three quarters of the year, a 44.12% decrease in revenue year-on-year [8]. - The company is involved in a legal dispute concerning a claim of approximately 332.6 million yuan related to a subsidiary's loan default, which has added to its operational challenges [7][8].